Your search history is turned on.
Date: April 30, 2024 Jurisdictions: Ontario
Exhibit 16.1 5400 W Cedar Ave Lakewood, CO 80226 Telephone: 303.953.1454 Fax: 303.945.7991 April 8, 2024 United States Securities and Exchange Commission Office of the Chief Accountant 100 F Street, N.E. Washington, D.C. 20549 Re: Medicine Man Technologies, Inc. Ladies and Gentleman: We have read the statements under item 4.01 in the Form 8-K dated April 8, 2024, of ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 5, 2024 Medicine Man Technologies, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 000-55450 46-5289499 (St...
Date: April 29, 2024 Jurisdictions: Ontario
SHWZ_2024_ARS.pdf UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2023 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition per...
Table of Contents MEDICINE MAN TECHNOLOGIES, INC. d/b/a SCHWAZZE 865 N. Albion St., Ste. 300 Denver, Colorado 80220 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To be Held June 20, 2024 To the Stockholders of Medicine Man Technologies, Inc.: NOTICE IS HEREBY GIVEN that the 2024 Annual Meeting of Stockholders (the Annual Meeting) of Medicine Man Technologies, Inc., a Nevada corp...
Date: April 9, 2024 Jurisdictions: Ontario
Date: April 3, 2024 Jurisdictions: Ontario
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 27, 2024 Medicine Man Technologies, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 000-55450 46-5289499 (S...
Date: April 2, 2024 Jurisdictions: Ontario
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Medicine Man Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 584680106 (CUSIP Number) 04/02/2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru...
Date: March 27, 2024 Jurisdictions: Ontario
Exhibit 31.2 CERTIFICATION I, Forrest Hoffmaster, certify that: 1. I have reviewed this annual report on Form 10-K of Medicine Man Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements we...
Exhibit 31.1 CERTIFICATION I, Forrest Hoffmaster, certify that: 1. I have reviewed this annual report on Form 10-K of Medicine Man Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements we...
Table of Contents 51 ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. You should read the following discussion and analysis of our financial condition and results of operations together with our accompanying consolidated financial statements and the related notes appearing elsewhere in this Report. In addition to historical informati...